Navigation Links
Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
Date:10/23/2008

HDACs appear to promote tighter winding of DNA around these proteins, leading to reduced access by gene transcription factors. This results in decreased expression of proteins involved in cell differentiation, cell cycle arrest and apoptotic elimination of damaged cells -- all of which contribute to the development of cancer. HDAC inhibitors are able to restore expression of tumor suppressor genes in a highly selective manner. Treatment with HDAC inhibitors also leads, indirectly, to inhibition of the expression of angiogenesis factors, helping to choke off the blood supply to tumors.

Although significant preclinical and clinical activity has been observed with HDAC inhibitors, most have characteristics which may limit their potential for clinical success or broad applicability. In contrast, Chidamide/HBI-8000 has selectivity, potency, PK and side effect profiles that make it ideal for use as a stand-alone therapeutic, as well as in combination with a wide variety of marketed anti-tumor agents.

HUYA's Integrated Co-development Model (ICM)

The global pharmaceutical industry faces a pressing need for new untapped sources of pre-clinical and clinical stage compounds for the drug development process. HUYA was one of the first companies to recognize China's potential to help meet this need through its burgeoning biotechnology industry and world-class talent pool. HUYA has pioneered an innovative approach -- the HUYA Integrated Co-development Model -- for partnering with Chinese research institutions and pharmaceutical companies. HUYA identifies and licenses the most promising pre-clinical and clinical stage compounds in China, leverages and extends the research efforts of its Chinese partners, and provides a bridge into the Western development process and biopharma market.

Because the compounds have already been validated through a rigorous discovery, selection and development process in China, this model streamlines and accelerates developmen
'/>"/>

SOURCE HUYA Bioscience International; Chipscreen Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... publication of the results of the Company,s 72-patient, ... eye drops) for the treatment of dry eye ... ® ) model.  The exploratory study was completed ... previously disseminated by the Company in a press ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3
... NEW YORK, Nov. 17, 2010 Reportlinker.com announces that ... catalogue: Global Pulse Oximeters Industry ... This report analyzes the worldwide markets for Pulse ... Types and End-Use Segments and covers non-invasive pulse oximeters ...
... Inc., a privately held specialty pharmaceutical company, today announced ... Executive Officer (CEO).  Thomas Beck, M.D., who was serving ... as Chief Medical Officer of the company. ... Phase 3 clinical trials to support a new drug ...
Cached Medicine Technology:Reportlinker Adds Global Pulse Oximeters Industry 2Reportlinker Adds Global Pulse Oximeters Industry 3Reportlinker Adds Global Pulse Oximeters Industry 4Reportlinker Adds Global Pulse Oximeters Industry 5Reportlinker Adds Global Pulse Oximeters Industry 6Reportlinker Adds Global Pulse Oximeters Industry 7Reportlinker Adds Global Pulse Oximeters Industry 8Reportlinker Adds Global Pulse Oximeters Industry 9Reportlinker Adds Global Pulse Oximeters Industry 10Reportlinker Adds Global Pulse Oximeters Industry 11Reportlinker Adds Global Pulse Oximeters Industry 12Reportlinker Adds Global Pulse Oximeters Industry 13Reportlinker Adds Global Pulse Oximeters Industry 14Reportlinker Adds Global Pulse Oximeters Industry 15Reportlinker Adds Global Pulse Oximeters Industry 16Reportlinker Adds Global Pulse Oximeters Industry 17Reportlinker Adds Global Pulse Oximeters Industry 18Reportlinker Adds Global Pulse Oximeters Industry 19Reportlinker Adds Global Pulse Oximeters Industry 20Reportlinker Adds Global Pulse Oximeters Industry 21Reportlinker Adds Global Pulse Oximeters Industry 22Reportlinker Adds Global Pulse Oximeters Industry 23Reportlinker Adds Global Pulse Oximeters Industry 24Reportlinker Adds Global Pulse Oximeters Industry 25Reportlinker Adds Global Pulse Oximeters Industry 26Reportlinker Adds Global Pulse Oximeters Industry 27Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 2Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 3
(Date:5/25/2015)... 25, 2015 World Patent Marketing, a ... the Hidee-Hose, an undergarment patent that allays women’s fears ... Women's Hosiery industry forecasts the market to reach $20.3 ... Creative Director of World Patent Marketing , "The ... ahead and is expected to maintain its lead. The ...
(Date:5/25/2015)... New York, New York (PRWEB) May 25, 2015 ... ( http://www.consumerinjurylawyers.com/depuy-pinnacle/lawsuit ) continue to move forward in ... District Court, Northern District of Texas. According to ... have asked the Court to modify the Case ... Disclose Health Information. Among other things, the Motion ...
(Date:5/25/2015)... Plains, NY (PRWEB) May 25, 2015 ... AP, principal of PBDW Architects in New York City, to ... is part of the hospital’s ongoing Legacy Lobby Lecture series, ... in White Plains. White is the great grandson of Stanford ... responsible for the design of Burke’s campus 100 years ago. ...
(Date:5/24/2015)... 24, 2015 For people who are ... Enterokinase Industry, 2009-2019 Market Research Report would be an ... exhaustive study on the present market scenario of this ... the growing Chinese market of this industry. The report ... status of the manufacturers in this industry. The report ...
(Date:5/24/2015)... 2015 ProPin is a set of ... X. Utilize ProPin to pin point locations on a map, ... , ProPin allows users to choose from 30 simplistic presets ... With on-screen controls, video editors can easily manipulate ProPin presets as ... mark with absolute ease. , Using ProPin is easy, simply drag ...
Breaking Medicine News(10 mins):Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 3Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2
... -- Alzheimer,s disease is gaining awareness as its ... with the disease. Previously unknown, misunderstood or hidden in ... family from Tioga, North Dakota -- are the subjects of ... for the disease, The Alzheimer,s Project shows there ...
... April 30 Rochester Medical Corporation (Nasdaq: ROCM ... March 31, 2009 compared to $9,215,000 for the second quarter ... of $361,000 or $.03 per diluted share for the current ... diluted share for the second quarter of last year.The approximate ...
... MillionCARLSBAD, Calif., April 30 Genoptix, Inc. (Nasdaq: ... reported revenues of $39.2 million for the first quarter ... changes in accounting estimates relating to prior periods. ... of $22.3 million for the comparable period in 2008, ...
... Mich. A new link between body fat and ... obesity,s health risk and could lead to new cancer ... food science and human nutrition researcher with the Michigan ... colon cancer, the third-leading killer of Americans, in part ...
... would like to announce the significant online growth of ... past few months Dynasplint(R) has been very busy building ... online. Their expansion includes two new web sites, a ... are intended to provide communication channels to their patients ...
... of children and grandchildren of DaVita teammates receive ... Inc. (NYSE: DVA ), a leading ... with chronic kidney disease (CKD), announced today that ... $1 million in funding for the educational pursuits ...
Cached Medicine News:Health News:The Alzheimer's Project HBO Documentary Puts Spotlight on Alzheimer's Disease; North Dakota Family Featured 2Health News:Rochester Medical Reports Second Quarter Results 2Health News:Rochester Medical Reports Second Quarter Results 3Health News:Rochester Medical Reports Second Quarter Results 4Health News:Rochester Medical Reports Second Quarter Results 5Health News:Rochester Medical Reports Second Quarter Results 6Health News:Rochester Medical Reports Second Quarter Results 7Health News:Rochester Medical Reports Second Quarter Results 8Health News:Rochester Medical Reports Second Quarter Results 9Health News:Rochester Medical Reports Second Quarter Results 10Health News:Rochester Medical Reports Second Quarter Results 11Health News:Rochester Medical Reports Second Quarter Results 12Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 2Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 3Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 4Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 5Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 6Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 7Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 8Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 9Health News:Cancer-obesity link discovery by MSU researchers could aid prevention efforts 2Health News:Dynasplint Systems, Inc. Launches Two New Web Sites Plus Social Media Tools 2Health News:DaVita Donates More Than $1 Million in Scholarship Funds for Teammates' Families 2
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Lorgnette pinhole occluder...
Maddox rod and occluder...
Black multi-pinhole occluder...
Medicine Products: